Testing early response to gender-affirming hormone treatment
Part of Mental health clinical trials.
This study looks at how people respond early after starting gender-confirming hormones. It may help doctors understand what changes happen soon after treatment starts and how to manage it safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can give informed consent in writing and understand the study.
- You are a transgender man diagnosed with “transsexualism” (ICD-10).
- You want to fully start gender-confirming hormone treatment.
- A qualified endocrinologist has approved you to take Nebido (a long-acting testosterone shot).
- You have no other hormone-related condition that could affect hormone control (for example certain adrenal, ovarian, thyroid, or cortisol problems).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether hormone therapy (such as testosterone or estrogen) helps reduce distress in teenagers who feel their gender does not match their body. It aims to see if starting hormones at this age improves mental well-being and overall quality of life.
This study looks at how starting testosterone therapy affects brain development in transgender and gender-diverse youth. It may help you and your doctor understand the changes to expect.
This study looks at how gender-affirming hormone therapy affects brain health and function in transgender adults. Researchers want to understand the effects of these hormones on the brain before and after treatment begins.
This study looks at how cross-sex hormone treatment affects the heart and fat in the liver. It aims to help understand the safety of hormone therapy in transgender individuals.
This study looks at how gender-affirming hormone therapy affects the immune system in trans individuals. It aims to learn how starting estrogen or testosterone might change immune function over time.
This study looks at starting gender-affirming hormone therapy (GAHT) for transgender people who have never had these treatments before. It may help you learn whether this approach is safe and effective for your goals as you begin care.
Hear when a new Gender Dysphoria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.